Drug Search Results
More Filters [+]

Flurbiprofen

Alternative Names: flurbiprofen, antadys, flubiprofen, strefen, sfpp, ansaid, ocufen
Latest Update: 2024-04-10
Latest Update Note: Clinical Trial Update

Product Description

Flurbiprofen is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve symptoms of arthritis (osteoarthritis and rheumatoid arthritis), such as inflammation, swelling, stiffness, and joint pain. However, this medicine does not cure arthritis and will help you only as long as you continue to take it. (Sourced from: https://www.mayoclinic.org/drugs-supplements/flurbiprofen-oral-route/precautions/drg-20069793?p=1)

Mechanisms of Action: COX1 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Topical,Transdermal

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: Arthritis, Rheumatoid | Arthritis | Osteoarthritis

Known Adverse Events: Abdominal Pain | Headache | Pain Unspecified | Constipation | Diarrhea | Dyspepsia | Edema

Company: Jiudian Pharmaceutical
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Flurbiprofen

Countries in Clinic: Australia, China, Germany, Japan, United States

Active Clinical Trial Count: 12

Highest Development Phases

Phase 3: Acute Pain|Osteoarthritis, Knee|Other|Pain, Postoperative

Phase 1: Agammaglobulinemia|Communicable Diseases|HIV Infections|Healthy Volunteers|Inflammation|Osteoarthritis|Respiratory Tract Infections|Shoulder Pain|Tennis Elbow|Tenosynovitis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT05955885

P1

Recruiting

Communicable Diseases|Respiratory Tract Infections

2024-07-01

jRCT2031230393

P1

Not yet recruiting

Healthy Volunteers

2024-03-31

2020-005217-41

P3

Completed

Acute Pain

2022-08-15

ID-082-103

P1

Completed

Healthy Volunteers

2022-04-13

70%

ID-082-103

P1

Completed

Healthy Volunteers

2022-04-13

70%

Recent News Events